Andrew Seacat
Executive Director Toxicology @ADARx Pharmaceuticals Inc.
Signup · Get unlimited contacts
WORK HISTORY
Executive Director Toxicology @ADARx Pharmaceuticals Inc.
San Diego, CA, US
EDUCATION
The Johns Hopkins University School of Hygeine and Public Health
Doctor of Philosophy (Ph.D.), Toxicology, Biochemical, Molecular Toxicology
SKILLS
ABOUT ANDREW SEACAT
An expert PHARMACEUTICAL TOXICOLOGIST AND LEADER in nonclinical drug development, toxicology, drug safety evaluation with 20+ years of experience in the pharmaceutical industry including small molecules and biologics. Leadership experience with passion for evaluating the safety of pharmaceuticals in drug development to bring new drugs to patients with critical unmet medical needs. Expertise in designing and implementing nonclinical development plans for drug candidates from early through advanced phases of development for multiple therapeutic areas. Skilled author and reviewer of nonclinical and clinical reports and preparation of documents for global regulatory submissions. Coordinates all matters of preclinical safety and efficacy with customers, business partners, academic collaborators, contract research organizations and health authorities, worldwide. Proven track record of making key data-driven drug development decisions and successful regulatory submissions globally. Key competencies include: • Peptide hormones • Long acting release drugs • Novel drug formulation platforms• Inhalation products and devices• Topical and intravitreal ocular drugs• Combination drug products• Safety assessment of impurities• CRO management • Regulatory interactions and submissions
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.